Global Breast Brachytherapy Market
Global Breast Brachytherapy Market

Breast Brachytherapy Comprehensive Study by Type (Invasive Lobular Carcinoma, Invasive Ductal Carcinoma, Others), End Users (Private Pharmacies, Hospital Pharmacies), Treatment (Surgery & Radiation Therapy, Targeted Therapy, Chemotherapy, Biologic Therapy, Hormone Therapy) Players and Region - Global Market Outlook to 2027

Breast Brachytherapy Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Jan 2022 Edition 231 Pages 61 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Breast Brachytherapy?
Breast brachytherapy helps stop breast most cancers from returning. Brachytherapy is used to deal with early-stage breast cancers that have now not unfold (metastasized) to different components of the body. Side results of brachytherapy can encompass swelling, bruising, bleeding, or ache and soreness at the spot the place the radiation used to be delivered. Brachytherapy used for gynecologic cancers or prostate most cancers can lead to non-permanent urinary symptoms, such as incontinence or ache on urination.

The market study is broken down by Type (Invasive Lobular Carcinoma, Invasive Ductal Carcinoma and Others) and major geographies with country level break-up.

The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global Breast Brachytherapy market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Varian Medical Systems, Inc. (United States), Elekta (Sweden), Accuray Incorporated (United States), Ion Beam Applications SA (Belgium), BD (United States), Eckert & Ziegler (Germany), Hitachi Ltd. (Japan), ICAD, Inc. (United States), IntraOp Medical, Inc. (United States) and IsoRay Medical, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Mevion Medical Systems, Inc. (United States), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel), ViewRay, Inc. (United States) and ZEISS Group (Germany).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Breast Brachytherapy market by Type, Application and Region.

On the basis of geography, the market of Breast Brachytherapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Private Pharmacies will boost the Breast Brachytherapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treatment, the sub-segment i.e. Surgery & Radiation Therapy will boost the Breast Brachytherapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

In 2020, Vivos Inc announced that it has completed its submission to the FDA seeking Breakthrough Device Designation for Radiogel. The company has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals (Isopet) and in humans (Radiogel).


Market Trend
  • New, Innovative Treatments such as Personalized Therapies and Immunotherapies

Market Drivers
  • Increasing Breast Cancer
  • Higher R&D Spending
  • Rising Government Initiatives to Increase Awareness

Opportunities
  • Rising Healthcare Expenditure across Developing Countries

Restraints
  • Lack of Skilled Radiologists

Challenges
  • Risk of Radiation Exposure


Key Target Audience
Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

1. What all players are profiled in the study?
The standard version of the report profiles players such as Varian Medical Systems, Inc. (United States), Elekta (Sweden), Accuray Incorporated (United States), Ion Beam Applications SA (Belgium), BD (United States), Eckert & Ziegler (Germany), Hitachi Ltd. (Japan), ICAD, Inc. (United States), IntraOp Medical, Inc. (United States) and IsoRay Medical, Inc. (United States) etc.

2. Can we have customized study for Breast Brachytherapy Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

3. What would be the Market Size of Breast Brachytherapy Market by 2027?
Analysts at AMA estimates Breast Brachytherapy Market to reach USD Million by 2027.
Report Objectives / Segmentation Covered
By Type
  • Invasive Lobular Carcinoma
  • Invasive Ductal Carcinoma
  • Others
By End Users
  • Private Pharmacies
  • Hospital Pharmacies

By Treatment
  • Surgery & Radiation Therapy
  • Targeted Therapy
  • Chemotherapy
  • Biologic Therapy
  • Hormone Therapy

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Breast Cancer
      • 3.2.2. Higher R&D Spending
      • 3.2.3. Rising Government Initiatives to Increase Awareness
    • 3.3. Market Challenges
      • 3.3.1. Risk of Radiation Exposure
    • 3.4. Market Trends
      • 3.4.1. New, Innovative Treatments such as Personalized Therapies and Immunotherapies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Breast Brachytherapy, by Type, End Users, Treatment and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Breast Brachytherapy (Value)
      • 5.2.1. Global Breast Brachytherapy by: Type (Value)
        • 5.2.1.1. Invasive Lobular Carcinoma
        • 5.2.1.2. Invasive Ductal Carcinoma
        • 5.2.1.3. Others
      • 5.2.2. Global Breast Brachytherapy by: End Users (Value)
        • 5.2.2.1. Private Pharmacies
        • 5.2.2.2. Hospital Pharmacies
      • 5.2.3. Global Breast Brachytherapy by: Treatment (Value)
        • 5.2.3.1. Surgery & Radiation Therapy
        • 5.2.3.2. Targeted Therapy
        • 5.2.3.3. Chemotherapy
        • 5.2.3.4. Biologic Therapy
        • 5.2.3.5. Hormone Therapy
      • 5.2.4. Global Breast Brachytherapy Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Breast Brachytherapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Varian Medical Systems, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Elekta (Sweden)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Accuray Incorporated (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Ion Beam Applications SA (Belgium)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BD (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Eckert & Ziegler (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hitachi Ltd. (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ICAD, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. IntraOp Medical, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. IsoRay Medical, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Breast Brachytherapy Sale, by Type, End Users, Treatment and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Breast Brachytherapy (Value)
      • 7.2.1. Global Breast Brachytherapy by: Type (Value)
        • 7.2.1.1. Invasive Lobular Carcinoma
        • 7.2.1.2. Invasive Ductal Carcinoma
        • 7.2.1.3. Others
      • 7.2.2. Global Breast Brachytherapy by: End Users (Value)
        • 7.2.2.1. Private Pharmacies
        • 7.2.2.2. Hospital Pharmacies
      • 7.2.3. Global Breast Brachytherapy by: Treatment (Value)
        • 7.2.3.1. Surgery & Radiation Therapy
        • 7.2.3.2. Targeted Therapy
        • 7.2.3.3. Chemotherapy
        • 7.2.3.4. Biologic Therapy
        • 7.2.3.5. Hormone Therapy
      • 7.2.4. Global Breast Brachytherapy Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Breast Brachytherapy: by Type(USD Million)
  • Table 2. Breast Brachytherapy Invasive Lobular Carcinoma , by Region USD Million (2016-2021)
  • Table 3. Breast Brachytherapy Invasive Ductal Carcinoma , by Region USD Million (2016-2021)
  • Table 4. Breast Brachytherapy Others , by Region USD Million (2016-2021)
  • Table 5. Breast Brachytherapy: by End Users(USD Million)
  • Table 6. Breast Brachytherapy Private Pharmacies , by Region USD Million (2016-2021)
  • Table 7. Breast Brachytherapy Hospital Pharmacies , by Region USD Million (2016-2021)
  • Table 8. Breast Brachytherapy: by Treatment(USD Million)
  • Table 9. Breast Brachytherapy Surgery & Radiation Therapy , by Region USD Million (2016-2021)
  • Table 10. Breast Brachytherapy Targeted Therapy , by Region USD Million (2016-2021)
  • Table 11. Breast Brachytherapy Chemotherapy , by Region USD Million (2016-2021)
  • Table 12. Breast Brachytherapy Biologic Therapy , by Region USD Million (2016-2021)
  • Table 13. Breast Brachytherapy Hormone Therapy , by Region USD Million (2016-2021)
  • Table 14. South America Breast Brachytherapy, by Country USD Million (2016-2021)
  • Table 15. South America Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 16. South America Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 17. South America Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 18. Brazil Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 19. Brazil Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 20. Brazil Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 21. Argentina Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 22. Argentina Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 23. Argentina Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 24. Rest of South America Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 25. Rest of South America Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 26. Rest of South America Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 27. Asia Pacific Breast Brachytherapy, by Country USD Million (2016-2021)
  • Table 28. Asia Pacific Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 29. Asia Pacific Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 30. Asia Pacific Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 31. China Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 32. China Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 33. China Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 34. Japan Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 35. Japan Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 36. Japan Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 37. India Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 38. India Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 39. India Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 40. South Korea Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 41. South Korea Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 42. South Korea Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 43. Taiwan Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 44. Taiwan Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 45. Taiwan Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 46. Australia Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 47. Australia Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 48. Australia Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 49. Rest of Asia-Pacific Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 50. Rest of Asia-Pacific Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 52. Europe Breast Brachytherapy, by Country USD Million (2016-2021)
  • Table 53. Europe Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 54. Europe Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 55. Europe Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 56. Germany Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 57. Germany Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 58. Germany Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 59. France Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 60. France Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 61. France Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 62. Italy Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 63. Italy Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 64. Italy Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 65. United Kingdom Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 66. United Kingdom Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 67. United Kingdom Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 68. Netherlands Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 69. Netherlands Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 70. Netherlands Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 71. Rest of Europe Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 72. Rest of Europe Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 73. Rest of Europe Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 74. MEA Breast Brachytherapy, by Country USD Million (2016-2021)
  • Table 75. MEA Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 76. MEA Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 77. MEA Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 78. Middle East Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 79. Middle East Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 80. Middle East Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 81. Africa Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 82. Africa Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 83. Africa Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 84. North America Breast Brachytherapy, by Country USD Million (2016-2021)
  • Table 85. North America Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 86. North America Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 87. North America Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 88. United States Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 89. United States Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 90. United States Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 91. Canada Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 92. Canada Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 93. Canada Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 94. Mexico Breast Brachytherapy, by Type USD Million (2016-2021)
  • Table 95. Mexico Breast Brachytherapy, by End Users USD Million (2016-2021)
  • Table 96. Mexico Breast Brachytherapy, by Treatment USD Million (2016-2021)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Breast Brachytherapy: by Type(USD Million)
  • Table 108. Breast Brachytherapy Invasive Lobular Carcinoma , by Region USD Million (2022-2027)
  • Table 109. Breast Brachytherapy Invasive Ductal Carcinoma , by Region USD Million (2022-2027)
  • Table 110. Breast Brachytherapy Others , by Region USD Million (2022-2027)
  • Table 111. Breast Brachytherapy: by End Users(USD Million)
  • Table 112. Breast Brachytherapy Private Pharmacies , by Region USD Million (2022-2027)
  • Table 113. Breast Brachytherapy Hospital Pharmacies , by Region USD Million (2022-2027)
  • Table 114. Breast Brachytherapy: by Treatment(USD Million)
  • Table 115. Breast Brachytherapy Surgery & Radiation Therapy , by Region USD Million (2022-2027)
  • Table 116. Breast Brachytherapy Targeted Therapy , by Region USD Million (2022-2027)
  • Table 117. Breast Brachytherapy Chemotherapy , by Region USD Million (2022-2027)
  • Table 118. Breast Brachytherapy Biologic Therapy , by Region USD Million (2022-2027)
  • Table 119. Breast Brachytherapy Hormone Therapy , by Region USD Million (2022-2027)
  • Table 120. South America Breast Brachytherapy, by Country USD Million (2022-2027)
  • Table 121. South America Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 122. South America Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 123. South America Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 124. Brazil Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 125. Brazil Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 126. Brazil Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 127. Argentina Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 128. Argentina Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 129. Argentina Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 130. Rest of South America Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 131. Rest of South America Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 132. Rest of South America Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 133. Asia Pacific Breast Brachytherapy, by Country USD Million (2022-2027)
  • Table 134. Asia Pacific Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 135. Asia Pacific Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 136. Asia Pacific Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 137. China Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 138. China Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 139. China Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 140. Japan Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 141. Japan Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 142. Japan Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 143. India Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 144. India Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 145. India Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 146. South Korea Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 147. South Korea Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 148. South Korea Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 149. Taiwan Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 150. Taiwan Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 151. Taiwan Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 152. Australia Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 153. Australia Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 154. Australia Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 155. Rest of Asia-Pacific Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 156. Rest of Asia-Pacific Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 157. Rest of Asia-Pacific Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 158. Europe Breast Brachytherapy, by Country USD Million (2022-2027)
  • Table 159. Europe Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 160. Europe Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 161. Europe Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 162. Germany Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 163. Germany Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 164. Germany Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 165. France Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 166. France Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 167. France Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 168. Italy Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 169. Italy Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 170. Italy Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 171. United Kingdom Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 172. United Kingdom Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 173. United Kingdom Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 174. Netherlands Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 175. Netherlands Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 176. Netherlands Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 177. Rest of Europe Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 178. Rest of Europe Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 179. Rest of Europe Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 180. MEA Breast Brachytherapy, by Country USD Million (2022-2027)
  • Table 181. MEA Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 182. MEA Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 183. MEA Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 184. Middle East Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 185. Middle East Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 186. Middle East Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 187. Africa Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 188. Africa Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 189. Africa Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 190. North America Breast Brachytherapy, by Country USD Million (2022-2027)
  • Table 191. North America Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 192. North America Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 193. North America Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 194. United States Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 195. United States Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 196. United States Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 197. Canada Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 198. Canada Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 199. Canada Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 200. Mexico Breast Brachytherapy, by Type USD Million (2022-2027)
  • Table 201. Mexico Breast Brachytherapy, by End Users USD Million (2022-2027)
  • Table 202. Mexico Breast Brachytherapy, by Treatment USD Million (2022-2027)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Breast Brachytherapy: by Type USD Million (2016-2021)
  • Figure 5. Global Breast Brachytherapy: by End Users USD Million (2016-2021)
  • Figure 6. Global Breast Brachytherapy: by Treatment USD Million (2016-2021)
  • Figure 7. South America Breast Brachytherapy Share (%), by Country
  • Figure 8. Asia Pacific Breast Brachytherapy Share (%), by Country
  • Figure 9. Europe Breast Brachytherapy Share (%), by Country
  • Figure 10. MEA Breast Brachytherapy Share (%), by Country
  • Figure 11. North America Breast Brachytherapy Share (%), by Country
  • Figure 12. Global Breast Brachytherapy share by Players 2021 (%)
  • Figure 13. Global Breast Brachytherapy share by Players (Top 3) 2021(%)
  • Figure 14. Global Breast Brachytherapy share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Varian Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Varian Medical Systems, Inc. (United States) Revenue: by Geography 2021
  • Figure 18. Elekta (Sweden) Revenue, Net Income and Gross profit
  • Figure 19. Elekta (Sweden) Revenue: by Geography 2021
  • Figure 20. Accuray Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 21. Accuray Incorporated (United States) Revenue: by Geography 2021
  • Figure 22. Ion Beam Applications SA (Belgium) Revenue, Net Income and Gross profit
  • Figure 23. Ion Beam Applications SA (Belgium) Revenue: by Geography 2021
  • Figure 24. BD (United States) Revenue, Net Income and Gross profit
  • Figure 25. BD (United States) Revenue: by Geography 2021
  • Figure 26. Eckert & Ziegler (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Eckert & Ziegler (Germany) Revenue: by Geography 2021
  • Figure 28. Hitachi Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Hitachi Ltd. (Japan) Revenue: by Geography 2021
  • Figure 30. ICAD, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. ICAD, Inc. (United States) Revenue: by Geography 2021
  • Figure 32. IntraOp Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. IntraOp Medical, Inc. (United States) Revenue: by Geography 2021
  • Figure 34. IsoRay Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. IsoRay Medical, Inc. (United States) Revenue: by Geography 2021
  • Figure 36. Global Breast Brachytherapy: by Type USD Million (2022-2027)
  • Figure 37. Global Breast Brachytherapy: by End Users USD Million (2022-2027)
  • Figure 38. Global Breast Brachytherapy: by Treatment USD Million (2022-2027)
  • Figure 39. South America Breast Brachytherapy Share (%), by Country
  • Figure 40. Asia Pacific Breast Brachytherapy Share (%), by Country
  • Figure 41. Europe Breast Brachytherapy Share (%), by Country
  • Figure 42. MEA Breast Brachytherapy Share (%), by Country
  • Figure 43. North America Breast Brachytherapy Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Varian Medical Systems, Inc. (United States)
  • Elekta (Sweden)
  • Accuray Incorporated (United States)
  • Ion Beam Applications SA (Belgium)
  • BD (United States)
  • Eckert & Ziegler (Germany)
  • Hitachi Ltd. (Japan)
  • ICAD, Inc. (United States)
  • IntraOp Medical, Inc. (United States)
  • IsoRay Medical, Inc. (United States)
Additional players considered in the study are as follows:
Mevion Medical Systems, Inc. (United States) , Panacea Medical Technologies Pvt. Ltd. (India) , P-cure Ltd. (Israel) , ViewRay, Inc. (United States) , ZEISS Group (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation